Pharmaceutical Patent-Antitrust Reverse Payment Settlements and Product Hopping

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service. Resources, Science, and Industry Division

Language:

English

Subjects (All):

Actions and defenses.

Antitrust law.

Competition.

Drugs.

Physical Description:

1 online resource

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

[United States] [publisher not identified] 2015

Summary:

Introduces and analyzes innovation and competition policy issues associated with the pharmaceutical industry. Describes the Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Act, which revised patent laws as applied to pharmaceutical products; and considers its implications upon the availability of generic substitutes for brand-name medications. Provides basic review of antitrust law, addresses judicial developments with respect to reverse payment settlements and product hopping, and summarizes Congressional issues and possible alternatives

Notes:

CRS Report

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Nov. 2015). Reuse except for individual research requires license from ProQuest, LLC

Vendor supplied data

Other Format:

Microfiche version Library of Congress. Congressional Research Service. Resources, Science, and Industry Division. Pharmaceutical Patent-Antitrust

Publisher Number:

CRS-2015-RSI-0532

Access Restriction:

Restricted for use by site license